Literature DB >> 15540998

The extent of axonal loss in the long tracts in hereditary spastic paraplegia.

G C Deluca1, G C Ebers, M M Esiri.   

Abstract

Hereditary spastic paraplegia (HSP) comprises a group of inherited neurodegenerative disorders with the shared characteristics of progressive weakness and spasticity predominantly affecting the lower limbs. Limited pathological accounts have described a 'dying back' axonal degeneration in this disease. However, the distribution and extent of axonal loss has not been elucidated in a quantitative way. We have studied post-mortem material from six HSP patients and 32 controls in detail. The population of axons was examined quantitatively in the corticospinal tracts from the medulla to the lumbar spinal cord and the sensory tracts from the lumbar to upper cervical spinal cord. Myelin and axon-stained sections were employed to estimate the notional area and axonal density, respectively, of both tracts. Our results indicate that in the corticospinal tracts there is a significant reduction in area and axonal density at all levels investigated in HSP compared to controls. In the corticospinal tracts, the ratio of medulla and lumbar total axonal number was significantly greater in HSP cases compared to controls suggesting more pronounced axonal loss in the distal neuraxis in HSP than in controls. The sensory tracts in HSP, in contrast, showed a significant reduction in area and axonal density only in the upper regions of the spinal cord. Similar to the corticospinal tracts, the ratio of lumbar and upper cervical cord total axonal number in the sensory tracts was increased in HSP cases compared to controls. These findings are consistent with a length-dependent 'dying back' axonopathy. Nerve fibre loss was not size-selective with both small and large diameter fibres affected. In HSP, axonal loss is widespread and symmetrical and its extent tract-specific. The characterization of the nature of axonal loss in HSP, where this is a primary phenomenon, may help the interpretation of axonal loss in conditions such as multiple sclerosis where the sequence of events is less clear.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15540998     DOI: 10.1111/j.1365-2990.2004.00587.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  75 in total

Review 1.  Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system.

Authors:  Nicholas M Kanaan; Gustavo F Pigino; Scott T Brady; Orly Lazarov; Lester I Binder; Gerardo A Morfini
Journal:  Exp Neurol       Date:  2012-06-19       Impact factor: 5.330

Review 2.  Recent advances in the genetics of spastic paraplegias.

Authors:  Giovanni Stevanin; Merle Ruberg; Alexis Brice
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

3.  Modeling Axonal Defects in Hereditary Spastic Paraplegia with Human Pluripotent Stem Cells.

Authors:  Kyle R Denton; Chongchong Xu; Harsh Shah; Xue-Jun Li
Journal:  Front Biol (Beijing)       Date:  2016-09-28

4.  REEPing the benefits of an animal model of hereditary spastic paraplegia.

Authors:  Ariel Y Deutch; Peter Hedera; Roger J Colbran
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

5.  The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1.

Authors:  Emmanuel J Botzolakis; Jiali Zhao; Katharine N Gurba; Robert L Macdonald; Peter Hedera
Journal:  Mol Cell Neurosci       Date:  2010-09-21       Impact factor: 4.314

6.  Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking.

Authors:  Jiali Zhao; Peter Hedera
Journal:  Mol Cell Neurosci       Date:  2012-10-16       Impact factor: 4.314

7.  Subtle Imaging Findings Aid the Diagnosis of Adolescent Hereditary Spastic Paraplegia and Ataxia.

Authors:  Franca Wagner; David S Titelbaum; Renate Engisch; Emily K Coskun; Jeff L Waugh
Journal:  Clin Neuroradiol       Date:  2018-01-29       Impact factor: 3.649

8.  1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C.

Authors:  G Morfini; G Pigino; K Opalach; Y Serulle; J E Moreira; M Sugimori; R R Llinás; S T Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-07       Impact factor: 11.205

9.  Hereditary spastic paraplegia-associated mutations in the NIPA1 gene and its Caenorhabditis elegans homolog trigger neural degeneration in vitro and in vivo through a gain-of-function mechanism.

Authors:  Jiali Zhao; Dawn S Matthies; Emmanuel J Botzolakis; Robert L Macdonald; Randy D Blakely; Peter Hedera
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

10.  Congenital bovine spinal dysmyelination is caused by a missense mutation in the SPAST gene.

Authors:  Bo Thomsen; Peter H Nissen; Jørgen S Agerholm; Christian Bendixen
Journal:  Neurogenetics       Date:  2009-08-28       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.